Paediatric prescribing: why children are not small adults
Editors' pick 2014
Clinical trials in children
Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct
The development and assessment of biological treatments for children
Paediatric pharmacokinetics: key considerations
Formulations for children: problems and solutions
Pharmacogenomics – how close/far are we to practising individualized medicine for children?
Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?
The development of a national children's formulary
Improving antibiotic prescribing for children in the resource-poor setting
ICH E14 Q&A(R2) document: commentary on the further updated recommendations on thorough QT studies*
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Safety, pharmacokinetics, pharmacogenomics and QT concentration−effect modelling of the SirT1 inhibitor selisistat in healthy volunteers
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease
Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1
Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study
High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids
Safety of intravenous β-adrenoceptor blockers for computed tomographic coronary angiography
Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation